CRISPR/Cas9 technology generated an A to G nucleotide change at position 1009 resulting in a methionine to valine substitution at amino acid 337 in exon 6. Analysis of mRNA levels and protein levels in the brain shows no difference in expression level from wild-type. Splicing of mRNAs regulated by TARDBP is deregulated in spinal cords, indicating a gain of splicing function. The M337V mutation is seen in patients with amyotrophic lateral sclerosis. (J:285477)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count